Efficacy and safety of subcutaneous vivaglobin® replacement therapy in previously untreated patients with primary immunodeficiency: a prospective, multicenter study. [electronic resource]
Producer: 20120413Description: 952-61 p. digitalISSN:- 1573-2592
- Adolescent
- Adult
- Aged
- Anti-Infective Agents -- administration & dosage
- Child
- Child, Preschool
- Female
- Follow-Up Studies
- Humans
- Immunoglobulin G -- blood
- Immunoglobulins -- administration & dosage
- Immunoglobulins, Intravenous -- administration & dosage
- Immunologic Deficiency Syndromes -- blood
- Infant
- Injections, Subcutaneous
- Italy
- Male
- Middle Aged
- Prospective Studies
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.